Lidocaine (Asset 1)
Lidothol Es System
Product Images NDC 83881-445
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidothol Es (NDC 83881-445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Clinic Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Menthol (Asset 2)
Figure1 (Asset 3)
Figure2 (Asset 4)
This text provides a detailed description of the proposed metabolic pathway of menthol. It outlines the conversion of menthol to various metabolites such as para-Menthane-3,7-diol, 3,8-Dihydro-para-menthane-7-carboxylic acid, para-Menthane-3,8-diol, para-Menthane-3,9-diol, and Menthol-9-carboxylic acid, detailing their excretion routes through urine and feces. The diagram suggests a pattern of metabolite transformation and enterohepatic circulation of menthol within the body.*
Logo (Clinicpharma)
Lidothol Es Carton Back (Lidothol Es Carton Back 011426)
This text provides drug information about an external anesthetic containing menthol for temporary pain relief. It includes warnings about not using the product on the face, damaged skin, or in the eyes. The directions explain how to apply and remove the product, with a note to avoid storing it in direct sunlight. The product is designed for all-night hold and is water-resistant. For questions or comments, consumers are advised to contact the manufacturer at (800) 224-2048. *
Lidothol Es Carton Front (Lidothol Es Carton Front 011426)
Di Table (Di Table)
Table1 (Table1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
